SCHEMBL28722253

SCHEMBL28722253

O=[N+]([O-])c1ccc2c(c1)Sc1cnc(O)nc1N2

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SNCA P37840 8/20 0.54
▸ NOX1 Q9Y5S8 1/20 0.47
▸ MAPT P10636 3/20 0.39
▸ NOS1 P29475 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ MAOB P27338 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.36
▸ CAPN9 O14815 1/20 0.36
▸ CASP3 P42574 1/20 0.36
▸ TXNRD1 Q16881 1/20 0.35
▸ TXNRD3 Q86VQ6 1/20 0.35
▸ TXNRD2 Q9NNW7 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ GABRA1 P14867 1/20 0.35
▸ GABRG2 P18507 1/20 0.35
▸ GABRB3 P28472 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29625234 0.78 SNCA (0.84) SNCANOX1MAPTLMNACYP3A4
SCHEMBL1208092 0.78 SNCA (0.84) SNCANOX1MAPTLMNACYP3A4
SCHEMBL28724407 0.74 NOX1 (0.50) SNCANOX1MAPTLMNACYP3A4
SCHEMBL30867073 0.72 SNCA (0.79) SNCANOX1MAPTCYP3A4CAPN9
SCHEMBL29214094 0.72 SNCA (0.79) SNCANOX1MAPTCYP3A4CAPN9
SCHEMBL30769632 0.71 SNCA (1.00) SNCANOX1MAPTLMNACYP3A4
SCHEMBL239724 0.71 SNCA (1.00) SNCANOX1MAPTLMNACYP3A4
SCHEMBL14571431 0.71 SNCA (0.72) SNCANOX1MAPTCYP3A4CAPN9
Dimethyl Sulfoxide SCHEMBL18398818 0.71 SNCA (0.72) SNCANOX1MAPTCYP3A4ALDH1A1
SCHEMBL26017578 0.71 SNCA (0.49) SNCANOX1MAPTALOX15ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114340680-A Trans-cyclooctene bioorthogonal agents and uses in cancer and immunotherapy 坦博公司 2022-04-12 — — CN disclosed
Send feedback